Suchergebnisse - "Tan, Qiaoyun"

PubPharm (20)

1

High-throughput antigen microarray identifies longitudinal prognostic autoantibody for chemoimmunotherapy in advanced non-small cell lung cancer

enthalten in: Molecular & cellular proteomics : MCP | 2024

von Dai, L. | Tan, Q. | Li, L. | +13

2

Identification of novel prognostic autoantibodies in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone via a high-throughput antigen microarray

enthalten in: Cancer | 2024

von Dai, L. | Chen, H. | Tan, Q. | +14

3

Longitudinal plasma proteomic analysis identifies biomarkers and combinational targets for anti-PD1-resistant cancer patients

enthalten in: Cancer immunology, immunotherapy : CII | 2024

von Tan, Q. | Gao, R. | Zhang, X. | +12

4

An immunosuppressive subtype of senescent tumor cells predicted worse immunotherapy response in lung adenocarcinoma

enthalten in: iScience | 2023

von Fan, G. | Xie, T. | Tan, Q. | +4

5

Proteomics Identifies Circulating TIMP-1 as a Prognostic Biomarker for Diffuse Large B-Cell Lymphoma

enthalten in: Molecular & cellular proteomics : MCP | 2023

von Lou, N. | Wang, G. | Wang, Y. | +15

6

Human Autoantigen Atlas : Searching for the Hallmarks of Autoantigens

enthalten in: Journal of proteome research | 2023

von Wang, D. | Yang, D. | Yang, L. | +18

7

Gut Streptococcus is a microbial marker for the occurrence and liver metastasis of pancreatic cancer

enthalten in: Frontiers in microbiology | 2023

von Yang, J. | Ma, Y. | Tan, Q. | +6

8

Radiation therapy in the era of immune treatment for hepatocellular carcinoma

enthalten in: Frontiers in immunology | 2023

von Chen, L. | Zhang, R. | Lin, Z. | +3

9

Identification of novel serological autoantibodies in Chinese prostate cancer patients using high-throughput protein arrays

enthalten in: Cancer immunology, immunotherapy : CII | 2023

von Lou, N. | Zheng, C. | Wang, Y. | +7

10

Anti-PD1/PDL1 IgG subclass distribution in ten cancer types and anti-PD1 IgG4 as biomarker for the long time survival in NSCLC with anti-PD1 therapy

enthalten in: Cancer immunology, immunotherapy : CII | 2022

von Tan, Q. | Dai, L. | Wang, Y. | +20